13F-HR filed by TYNDALL CAPITAL PARTNERS L P
TYNDALL CAPITAL PARTNERS L P filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 3 holding rows worth $2,709,000.
- Accession
- 0000905718-19-000929
- Filer
- CIK 1219314
- Filed
- 2019-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 3 entries on the cover page, a total value of $2,709,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,709,000 with VALUE read as thousands by filing date, 13F file number 028-10427. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MMA Capital Management LLC | 55315D105 | COM | 72,552 | $2,177,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ONCONOVA THERAPEUTIC | 68232V405 | Common Stock | 616,389 | $524,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
| ONCONOVA THERAPEUTICS INC | 68232V116 | *W EXP 07/11/202 | 390,624 | $8,000 | thousands by filing date | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000905718-19-000929 | this filing | 2019-11-14 | acceptance time not in the bulk data set |